急性心肌梗死早期使用倍他乐克预防心律失常的疗效分析  

Antiarrhythmic effect of early treat with betaloc after acute myocardial infarction

作　　者：何晓燕[1] 罗裕[1] 张代富[1] 胡铂[1] 

机构地区：[1]同济大学附属东方医院心内科,上海市200120

出　　处：《中国心血管病研究》2008年第6期413-415,共3页Chinese Journal of Cardiovascular Research

摘　　要：目的探讨急性心梗早期使用倍他乐克减少室性或室上性心律失常的作用。方法将232例急性心梗病例随机分为2组:A组(治疗组)在常规治疗基础上口服倍他乐克25～50mg/次,一日2次;B组(对照组)仅予常规治疗。比较两组疗效。结果在治疗后的第3个月和第6个月时,倍他乐克组患者发生室性、室上性心律失常及心律失常性死亡的患者明显减少,与对照组相比差异具有统计学意义(P<0.05)。结论急性心梗早期使用倍他乐克能减少室性和室上性心律失常的发作。Objective To affirm if betaloc can reduce ventricular arrhythmia and supraventricular arrhythmia given early in acute myocardiol infarction （AMI）. Methods 232 patients with AMI were divided into 2 groups, B group was given conventional treatment,A group was given betaloc 25-50 mg,bid additionally.Results 3 and 6 months later, events of ventricular arrhythmia, supraventricular arrhythmia, decease of arrhythmia in group A were less than those in group B （P〈0.05）.Conclusion Given early in AMI,betaloc has a powerful antiarrhythmic effect in suppressing ventricular arrhythmias as well as supraventricular arrhythmias.

关 键 词：心肌梗死 倍他乐克 心律失常 

分 类 号：R542.22[医药卫生—心血管疾病] R541.7[医药卫生—内科学]